Previous 10 | Next 10 |
Smith & Nephew (SNN): Q3 Revenue of $1.2B (-4.0% Y/Y) in-line.Press Release For further details see: Smith & Nephew revenue in-line
Smith+Nephew announces remote Physical Therapy (PT) functionality; expanding its ARIA Care Management Platform for ASCs At-home PT adds convenience for patients with musculoskeletal problems and helps manage costs for payors and employers PR Newswire LONDON, Oct. 20, 202...
Aziyo Biologics, Inc. is slated to price its IPO on Wednesday, October 7th.From the prospectus:"We are a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on pa...
Integra and Smith & Nephew announced a deal wherein Smith & Nephew will acquire Integra's orthopedic extremities business for $240 million in cash. Integra's cobbled-together extremities portfolio could never make much headway, squeezed between better-established leaders and a...
Integra LifeSciences has sold a tiny part of its business to Smith & Nephew. Valued at 5% of the enterprise valuation, the deal is not spectacular, but addresses leverage a bit and creates a more focused business. I like the much more modest valuations, yet at the same time I ...
Smith+Nephew expands in higher-growth extremities segment through planned acquisition of Integra LifeSciences' Extremity Orthopaedics business PR Newswire LONDON, Sept. 29, 2020 LONDON , Sept. 29, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the glob...
Integra LifeSciences (IART) to sell its Extremity Orthopedics business to Smith+Nephew (SNN) for $240M in cash.The transaction is expected to close at or around the end of 2020 and will not have a material impact on 2020 financial results. The Extremity Orthopedics business generated rev...
Integra LifeSciences (IART) has agreed to sell its extremity orthopedics unit to Smith+Nephew (SNN) for $240M in cash. The transaction should close late next quarter.The company will, in turn, pay $41.5M to the Consortium of Focused Orthopedists, LLC, related to prior agreements for shoulder ...
LONDON , Sept. 16, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today welcomes the announcement that its campaign to develop and promote the T.I.M.E. clinical decision support tool (CDST) 1 was awarded Most Innovative in the category Excel...
LONDON , Sept. 15, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it has teamed up with Avail Medsystems ( Palo Alto, CA ) to provide remote, real-time collaboration services to its customers, directly in the OR. Smith+Nephew ...
News, Short Squeeze, Breakout and More Instantly...
Smith & Nephew SNATS Inc. Company Name:
SNN Stock Symbol:
NYSE Market:
Smith & Nephew SNATS Inc. Website:
Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI ◊ Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System fro...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and inspiring inclusion for individuals wishing to pursue a career in ort...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will sponsor tennis players participating in The Championships, Wimbledon 2024 to spotlight its advanced Sports Medicine portfolio alongside some of the greatest athletes in the world. Smith+Nephew endeavou...